clinicalomicsprowebdirectory
News
Topics
Informatics
Molecular Dx
New Products
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
eBooks
Inside Precision Medicine Live
Podcasts
Virtual Event
Webinars
On Demand Webinars
Subscribe
Create a Free Account
Log In
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Cell-Based Assays
High Speed Cell Sorter Allows Genome-Scale Studies of Complex Phenotypes
Allergic Diseases
Immunotherapy Can Induce Remission in Young Children with Peanut Allergy
Microbiome
NIH Earmarks $170M for the Nutrition for Precision Health Program
Genetic Disorders
Gene Therapy for Severe Form of Epilepsy Shows Promise
Neurological Disorders
Tau Interactome Map Suggests How Mutated Brain Protein Spreads
Topics
Informatics
Molecular Dx
New Products
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
All
eBooks
Inside Precision Medicine Live
Podcasts
Virtual Event
Webinars
Cancer Testing
Delivering Cancer Care Equity via In-House NGS Testing
On Demand Webinars
Digital Solutions to Alleviate NASH Clinical Trial Challenges
Cancer Testing
Podcast Series: Comprehensive Genomic Profiling
Virtual Event
Digital Insights to Tumor Biology
Subscribe
Create a Free Account
Log In
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Home
Companies
Roche
Roche
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Roche
Precision Medicine Platform Trial Aims to Develop Treatments for Rare Cancers
January 19, 2022
Roche
Spark Therapeutics Will Develop a New $575M Gene Therapy Center in...
December 20, 2021
Roche
Roche’s Genentech Taps Adaptimmune for T-Cell Therapy Collaboration that Could Top...
September 7, 2021
Roche
Artificial Intelligence Can Help Improve Bowel Cancer Treatment
April 22, 2021
Roche
Roche, Blueprint Medicines Target RET-Altered Cancers with $1.7B Partnership
July 14, 2020
Roche
Illumina Debuts Two New Sequencers, Inks Dx Deal with Roche
January 14, 2020
Roche
Illumina Prevails Against Ariosa in UK Patent Infringement Case
June 18, 2019
Roche
Flatiron Health, Foundation Medicine Publish Study Validating Clinico-Genomic Database
April 10, 2019
Roche
FDA Approves Roche CDx for Breast Cancer Combination Therapy Developed with...
March 11, 2019
Roche
Expanding into Gene Therapy, Roche Plans $4.8B Acquisition of Spark Therapeutics
February 25, 2019
Load more
Featured
High Speed Cell Sorter Allows Genome-Scale Studies of Complex Phenotypes
January 21, 2022
Immunotherapy Can Induce Remission in Young Children with Peanut Allergy
January 21, 2022
Gene Therapy for Severe Form of Epilepsy Shows Promise
January 20, 2022
Tau Interactome Map Suggests How Mutated Brain Protein Spreads
January 20, 2022
New Products
View All
Digital PCR Leverages Microfluidic Array Tech
October 26, 2021
Simplified PCR Cleanup and Plasmid Prep
October 19, 2021
Pharmacogenetics Home Collection Test Kit
October 19, 2021
Load more
![Roche has agreed to acquire Spark Therapeutics for $4.8 billion cash in a deal designed to expand the biopharma giant into gene therapy with the marketed Luxturna™ (voretigene neparvovec-rzyl) and a pipeline of other gene therapies. [Spark Therapeutics]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/03/2164-324x160.jpeg "Expanding into Gene Therapy, Roche Plans $4.8B Acquisition of Spark Therapeutics")
